| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $628.8M | -29.5% |
| Cost of Revenue | $1.25B | -10.4% |
| Gross Profit | -$624.9M | -23.1% |
| R&D Expense | $77.2M | -32.1% |
| SG&A Expense | $376.1M | -11.0% |
| Operating Income | -$2.02B | -50.3% |
| Interest Expense | $46.6M | +3.1% |
| Pre-tax Income | -$2.11B | -53.1% |
| Income Tax | -$2.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $205.7M | +52.3% |
| Accounts Receivable | $157.2M | -35.5% |
| Inventory | $682.6M | -29.0% |
| Current Assets | $1.48B | -17.3% |
| Total Assets | $3.60B | -26.5% |
| Current Liabilities | $748.5M | -22.4% |
| Total Liabilities | $1.80B | -10.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$728.6M | +34.2% |
| Capital Expenditures | $287.1M | -56.8% |
| Investing Cash Flow | -$402.4M | -155.3% |
| Financing Cash Flow | $983.2M | — |
| Free Cash Flow | -$1.02B | +42.7% |
| +63.5% |
| Net Income | -$2.10B | -53.8% |
| EPS (Basic) | -$2.68 | -16.5% |
| EPS (Diluted) | -$2.68 | -16.5% |
| Stockholders' Equity |
| $1.73B |
| -40.2% |